Bernadette Connaughton Appointed to Syneos Health Board of Directors

NEXT STORY
Pennant Reports Third Quarter Financial Results
PREV STORY
Adamis Pharmaceuticals Announces Third Quarter 2019 Financial Results and Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

GeneOne Life Science and Inovio Pharmaceuticals’ MERS Vaccine Approved for First-in-Human Study

SEOUL, South Korea, Nov. 19, 2015 (GLOBE NEWSWIRE) -- GeneOne Life Science Inc. (KSE:011000) ...

author_avatar
NASDAQ Market News

Catalyst Psychiatry Now Offering Mental Health Technology for Patients with Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD) in Corvallis

author_avatar
NASDAQ Market News

CytoDyn Announces Cancer Update: 12-month Analysis of 28 mTNBC Patients Receiving Leronlimab Suggests an Increase of 3600% in 12-month OS in 75% of Patients with a Lower Level of Circulating Cells After Leronlimab Induction or at Baseline; 12-month PFS Continues at Near 600% Increase

author_avatar
NASDAQ Market News